Sanara MedTech (SMTI) Return on Equity (2016 - 2025)
Historic Return on Equity for Sanara MedTech (SMTI) over the last 13 years, with Q3 2025 value amounting to 2.09%.
- Sanara MedTech's Return on Equity fell 18900.0% to 2.09% in Q3 2025 from the same period last year, while for Sep 2025 it was 2.09%, marking a year-over-year decrease of 18900.0%. This contributed to the annual value of 0.23% for FY2024, which is 1300.0% down from last year.
- Sanara MedTech's Return on Equity amounted to 2.09% in Q3 2025, which was down 18900.0% from 0.41% recorded in Q2 2025.
- In the past 5 years, Sanara MedTech's Return on Equity registered a high of 0.1% during Q4 2023, and its lowest value of 2.09% during Q3 2025.
- In the last 5 years, Sanara MedTech's Return on Equity had a median value of 0.2% in 2024 and averaged 0.32%.
- In the last 5 years, Sanara MedTech's Return on Equity skyrocketed by 8700bps in 2021 and then crashed by -18900bps in 2025.
- Quarter analysis of 5 years shows Sanara MedTech's Return on Equity stood at 0.24% in 2021, then rose by 26bps to 0.18% in 2022, then soared by 43bps to 0.1% in 2023, then crashed by -279bps to 0.38% in 2024, then tumbled by -451bps to 2.09% in 2025.
- Its Return on Equity was 2.09% in Q3 2025, compared to 0.41% in Q2 2025 and 0.44% in Q1 2025.